OMEGA-3-Polyunsaturated Fatty-Acids (N3-Pufa) In Patients With Peripheral Arterial Disease

NCT01367145 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

71

Enrollment

OTHER

Sponsor class

Conditions

Peripheral Arterial Disease

Interventions

DRUG: OMACOR
DRUG: Placebo

Sponsor

Medical University of Vienna